Executive Reshuffles: LLY, S and RY Companies in Focus
J&J Leads H1 Healthcare Deals as Big Pharma Dealmaking Returns: Report
Merck Keytruda With Eisai's Lenvima Succeeds in Late-stage Trial for Liver Cancer
Trending Stocks This Week as Market Bounces Back From Selloff
Merck Keytruda Cuts Mortality Risk in Gastric Cancer by 20%
GSK, ITeos Lung Cancer Therapy Outperforms Jemperli in Mid-stage Trial
Moderna Faces Analyst Downgrades Amid Revised R&D Restructured Strategy and Delayed Profitability Target
Arcus up 4% Following Merck Welireg Kidney Cancer Data
Merck & Co Unusual Options Activity
Summit Boosts Instil, BioNTech as Lead Drug Beats Merck's Keytruda
Catalyst Watch: FOMC, FedEx Earnings, Electronic Arts Event, and Triple Witching Day
Merck Goes Ex Dividend Monday
Correction: JP Morgan Maintains Overweight on Eli Lilly, Raises Price Target to $1100. Action Price Target Changed to Raises
Moderna Continues to Decline as Oppenheimer Latest to Downgrade
Citigroup Reinstates Buy on Eli Lilly, Announces $1060 Price Target
Eli Lilly Analyst Ratings
How do you view the recent "hawkish" stance of the Bank of Japan executives? Goldman Sachs: The next interest rate hike may still have to wait until January next year.
Goldman Sachs believes that when evaluating the timing of interest rate hikes, it is important to consider financial market stability and inflation trends. The bank predicts that January next year will be the best time to determine whether Japan's inflation will rebound, and based on this, determine that Japan will raise interest rates in January. However, if there is significant turmoil in the financial markets, the timing of the rate hike may become uncertain.
Eli Lilly Wins Buy as Citi Resumes Coverage on Obesity Prospects
Moderna Extends Losses as R&D Day Updates Lead to Downgrades
US stocks closing | NASDAQ, S&P joined hands for four consecutive positives, US stocks' seven giants all rose, with Meta up nearly 3% and Nvidia up nearly 2%.
In August, the PPI in the United States showed a cooling down of inflation, and the market slightly raised its bets on the Fed's aggressive interest rate cuts. US stocks rose together, with Nvidia up nearly 2%, while NIO Inc and XPeng fell more than 5%. The European Central Bank cut interest rates for the second time this year, but maintained a restrictive policy. European bonds fell, and the euro rebounded from its four-week low. Commodities rose across the board, with US oil briefly rising by 3.7%, gold reaching a new high with a nearly 2% increase, palladium rising by over 4%, and copper experiencing its largest two-month increase.